Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by sweenbyon Oct 20, 2010 1:59pm

300 Views

Post# 17588421

More showing that

TD might emerge as the ones to move this stock. glta

Most Recent Trades
Time	Price	Change	#Shares	Buyer	Seller
13:37:37	0.39	-0.01	12,000	7 TD Sec	7 TD Sec
13:35:14	0.40	0.00	500	89 Raymond James	7 TD Sec
13:34:51	0.40	0.00	439	124 Questrade	89 Raymond James
13:34:51	0.40	0.00	5,000	79 CIBC	7 TD Sec
13:34:51	0.40	0.00	500	1 Anonymous	7 TD Sec
13:34:51	0.40	0.00	6,000	7 TD Sec	7 TD Sec
11:22:23	0.41	0.01	24,000	7 TD Sec	1 Anonymous
11:14:23	0.41	0.01	500	124 Questrade	33 Canaccord
10:23:46	0.41	0.01	1,500	124 Questrade	14 ITG
09:57:28	0.41	0.01	2,000	85 Scotia	14 ITG